16.6 CVS Disease + Pregnancy Flashcards
A 27-year-old woman is 13 weeks pregnant. In the antenatal clinic, she is found to have an asymptomatic
heart murmur. A subsequent echocardiogram shows moderate to severe mitral stenosis.
a) List the causes of mitral stenosis. (15%)
> > Rheumatic fever
(commonest cause worldwide
but less common in
developed countries).
> > Infective endocarditis.
> > Degenerative calcification.
b) How do the cardiovascular changes in pregnancy exacerbate the pathophysiology of mitral stenosis?
(45%)
- > > 45% increase in intravascular volume: **
the fixed output of the left atrium
is unable to cope,
resulting in pulmonary oedema.
Increase in left atrial stretch predisposes
to atrial fibrillation and decompensation.
- > > 20% increase in heart rate:
shorter diastole so reduced time for flow
across stenosed valve,
reduces left ventricular filling,
reduces cardiac output (CO). - > > Normal pregnancy has 40% increase
in CO to cope with the 40%
increase in oxygen consumption
caused by the fetus and raised
maternal metabolism.
This increase cannot be facilitated with a
significantly stenosed valve,
resulting in decreased exercise tolerance,
dyspnoea, cyanosis.
- > > 20% reduction in systemic vascular resistance
in pregnancy causes reduction in
coronary artery perfusion,
resulting in risk of ischaemia.
c) Outline the specific management issues when she presents in established labour. (40%)
> > Decision regarding delivery mode
and location should have been made
antenatally
(tertiary centre with capabilities
of managing an urgent
valvotomy/valve replacement)
as she presented early in pregnancy.
> > Early communication between
senior anaesthetist, senior obstetrician,
cardiologist, cardiothoracic surgeon,
midwifery team.
> > Ensure cross-matched blood available
(she will tolerate volume loss
poorly and need replacement with
fluid that has oxygen-carrying capacity).
Vaginal
C section
Vaginal MS delivery
> > Airway and respiratory:
• Supplementary oxygen.
• Oxygen saturations monitoring.
• Avoid nitrous oxide or hypoxia,
which could raise pulmonary vascular
resistance.
> > Cardiovascular:
• Intra-arterial blood pressure monitoring
(neuraxial analgesia-related hypotension
should be managed promptly with α-agonist).
• ECG monitoring (tachycardia and
loss of sinus rhythm are deleterious
to cardiac output).
• Monitor for blood loss.
• Cautious intravenous fluids if
dehydrated due to poor intake in labour
(maintain left atrial filling).
• Left lateral tilt to ensure unobstructed
venous return.
• Monitor for effects of autotransfusion after delivery.
> > Neurological:
• Early epidural to avoid sympathetically
mediated heart rate increases,
cautious top-ups to avoid drop in
systemic vascular resistance,
α-agonist use as necessary.
> > Pharmacology:
• Syntocinon to be given as an
infusion rather than as a bolus to avoid
tachycardia and vasodilatation.
Ergometrine contraindicated as will
cause pulmonary vasoconstriction.
> > Obstetric:
• Continuous fetal monitoring:
fetal distress may be an indicator of poor
maternal haemodynamics.
• Consideration of instrumental
second stage to avoid maternal effort as
the associated valsalva will reduce venous return.
Mitral Stenosis and C section
Caesarean delivery:
» Airway and respiratory:
• Supplementary oxygen.
• Oxygen saturations monitoring.
• Avoid nitrous oxide or hypoxia, which could raise pulmonary vascular resistance.
> > Cardiovascular:
• Intra-arterial blood pressure monitoring –
reduced afterload must be
promptly managed with vasoconstrictor.
• ECG monitoring –
increased heart rate or loss of sinus rhythm is
deleterious to CO.
• Intravenous fluids to counteract
the effect of neuraxial block and to
maintain preload, but avoid left atrial overload.
• Replace blood with blood.
• Left lateral tilt to ensure unobstructed venous return.
• Monitor for the effects of
autotransfusion post delivery.
> > Neurological:
• Optimum mode of anaesthesia is
slow epidural top-up, combined
spinal and epidural with
low dose spinal component, or spinal catheter
to avoid sudden decrease in
systemic vascular resistance.
> > Pharmacology:
• If general anaesthesia is necessary,
ensure opioid at induction to
obtund the pressor response
and at a dose that obviates the need
for high-dose (vasodilatory) induction agent
(‘cardiac induction’).
Paediatricians to be alerted to this.
• Phenylephrine infusion to maintain
systemic vascular resistance
without inducing tachycardia.
• Avoid drugs that make tachycardia likely,
e.g. atropine.
• Short acting β-blockers if necessary.
• Syntocinon as an infusion to
avoid tachycardia and vasodilatation.
> > Obstetric:
• Early consideration of e.g.
B-lynch suture, intra-uterine balloon
or hysterectomy if excessive bleeding
as blood loss poorly
tolerated and pharmacological
options limited
(ergometrine causes pulmonary vasoconstriction
and hypertension,
prostaglandins cause bronchospasm
and may precipitate pulmonary oedema).